PYR Fundamental Analysis - PYRUM INNOVATIONS AG

Name: PYRUM INNOVATIONS AG (PYR) Stock
Brand: PYRUM INNOVATIONS AG
Rating: 3.5 (3 reviews)

Fundamental Rating

We assign a fundamental rating of 2 out of 10 to PYR. PYR was compared to 37 industry peers in the Commercial Services & Supplies industry. Both the profitability and financial health of PYR have multiple concerns. PYR is valued quite expensive, but it does show an excellent growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

PYR had negative earnings in the past year.

In the past year PYR has reported a negative cash flow from operations.

In the past 5 years PYR always reported negative net income.

In the past 5 years PYR always reported negative operating cash flow.

1.2 Ratios

PYR's Return On Assets of -16.35% is on the low side compared to the rest of the industry. PYR is outperformed by 81.08% of its industry peers.

With a Return On Equity value of -56.25%, PYR is not doing good in the industry: 78.38% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
ROA	-16.35%
ROE	-56.25%
ROIC	N/A

ROA(3y)-16.61%

ROA(5y)-17.55%

ROE(3y)-37.51%

ROE(5y)-37.1%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With an excellent Gross Margin value of 159.78%, PYR belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.

PYR's Gross Margin has improved in the last couple of years.

PYR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	159.78%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y16.22%

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

PYR does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for PYR has been increased compared to 1 year ago.

Compared to 1 year ago, PYR has a worse debt to assets ratio.

2.2 Solvency

PYR has an Altman-Z score of 1.30. This is a bad value and indicates that PYR is not financially healthy and even has some risk of bankruptcy.

PYR has a worse Altman-Z score (1.30) than 62.16% of its industry peers.

PYR has a Debt/Equity ratio of 1.67. This is a high value indicating a heavy dependency on external financing.

With a Debt to Equity ratio value of 1.67, PYR is not doing good in the industry: 67.57% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Debt/Equity	1.67
Debt/FCF	N/A
Altman-Z	1.3

ROIC/WACCN/A

WACC6.47%

2.3 Liquidity

A Current Ratio of 0.68 indicates that PYR may have some problems paying its short term obligations.

PYR's Current ratio of 0.68 is on the low side compared to the rest of the industry. PYR is outperformed by 81.08% of its industry peers.

A Quick Ratio of 0.51 indicates that PYR may have some problems paying its short term obligations.

The Quick ratio of PYR (0.51) is worse than 86.49% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.68
Quick Ratio	0.51

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

PYR shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.47%.

The Revenue has grown by 90.75% in the past year. This is a very strong growth!

The Revenue has been growing by 29.91% on average over the past years. This is a very strong growth!

EPS 1Y (TTM)6.47%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-57.6%

Revenue 1Y (TTM)90.75%

Revenue growth 3Y29.92%

Revenue growth 5YN/A

Sales Q2Q%103.79%

3.2 Future

The Earnings Per Share is expected to grow by 23.48% on average over the next years. This is a very strong growth

The Revenue is expected to grow by 103.25% on average over the next years. This is a very strong growth

EPS Next Y3.81%

EPS Next 2Y14.06%

EPS Next 3Y21.86%

EPS Next 5Y23.48%

Revenue Next Year150%

Revenue Next 2Y228.89%

Revenue Next 3Y183.57%

Revenue Next 5Y103.25%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

PYR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PYR. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as PYR's earnings are expected to grow with 21.86% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y14.06%

EPS Next 3Y21.86%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for PYR!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

PYRUM INNOVATIONS AG

FRA:PYR (11/6/2025, 7:00:00 PM)

27.9

+0.7 (+2.57%)

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCommercial & Professional Services

GICS IndustryCommercial Services & Supplies

Earnings (Last)11-22 2024-11-22

Earnings (Next)N/A N/A

Inst Owners1.07%

Inst Owner ChangeN/A

Ins Owners16.54%

Ins Owner ChangeN/A

Market Cap106.58M

Revenue(TTM)2.58M

Net Income(TTM)-9935400

Analysts82.86

Price Target57.12 (104.73%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)25.7%

PT rev (3m)25.7%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)17.01%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)-3.22%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	41.29
P/FCF	N/A
P/OCF	N/A
P/B	6.03
P/tB	8.15
EV/EBITDA	N/A

EPS(TTM)-2.84

EYN/A

EPS(NY)-2.04

Fwd EYN/A

FCF(TTM)-3.6

FCFYN/A

OCF(TTM)-1.25

OCFYN/A

SpS0.68

BVpS4.62

TBVpS3.42

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-16.35%
ROE	-56.25%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	159.78%
FCFM	N/A

ROA(3y)-16.61%

ROA(5y)-17.55%

ROE(3y)-37.51%

ROE(5y)-37.1%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y16.22%

GM growth 5YN/A

F-Score5

Asset Turnover0.04

Health

		Industry Rank	Sector Rank
Debt/Equity	1.67
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	256.86%
Cap/Sales	347.9%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.68
Quick Ratio	0.51
Altman-Z	1.3

F-Score5

WACC6.47%

ROIC/WACCN/A

Cap/Depr(3y)564.51%

Cap/Depr(5y)411.79%

Cap/Sales(3y)1204.38%

Cap/Sales(5y)853.41%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)6.47%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-57.6%

EPS Next Y3.81%

EPS Next 2Y14.06%

EPS Next 3Y21.86%

EPS Next 5Y23.48%

Revenue 1Y (TTM)90.75%

Revenue growth 3Y29.92%

Revenue growth 5YN/A

Sales Q2Q%103.79%

Revenue Next Year150%

Revenue Next 2Y228.89%

Revenue Next 3Y183.57%

Revenue Next 5Y103.25%

EBIT growth 1Y8.68%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year46.8%

EBIT Next 3Y48.39%

EBIT Next 5Y45.85%

FCF growth 1Y38.94%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y21.49%

OCF growth 3YN/A

OCF growth 5YN/A

PYRUM INNOVATIONS AG / PYR.DE FAQ

What is the fundamental rating for PYR stock?

ChartMill assigns a fundamental rating of 2 / 10 to PYR.DE.

What is the valuation status of PYRUM INNOVATIONS AG (PYR.DE) stock?

ChartMill assigns a valuation rating of 1 / 10 to PYRUM INNOVATIONS AG (PYR.DE). This can be considered as Overvalued.

What is the profitability of PYR stock?

PYRUM INNOVATIONS AG (PYR.DE) has a profitability rating of 1 / 10.

What is the expected EPS growth for PYRUM INNOVATIONS AG (PYR.DE) stock?

The Earnings per Share (EPS) of PYRUM INNOVATIONS AG (PYR.DE) is expected to grow by 3.81% in the next year.

PYRUM INNOVATIONS AG (PYR.DE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

PYRUM INNOVATIONS AG / PYR.DE FAQ

What is the fundamental rating for PYR stock?

What is the valuation status of PYRUM INNOVATIONS AG (PYR.DE) stock?

What is the profitability of PYR stock?

What is the expected EPS growth for PYRUM INNOVATIONS AG (PYR.DE) stock?